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Editorial  Commentary 
Sensitivity  to  light  and 
noise 
Neurophvsioloeical  experiments  in 
laboraior;  an&s  and&humans  have 
COlWid.&lY  demonstrated  the 
developm%  of  "Celltral sensiti- 
z&ion”  in  response  to  repeated 
discharge  of  -  primary.  a&rent 
nociceptors  (1,  2).  Convergence  of 
low-threshold  mechanoreceptive 
neurons  on  spinothalamic  tract*neu- 
rons  that  have  been  sensitized  bv 
nociceptive  input  is  thought 
account  for  tenderness  around  tlE 
site of injury. It now seems clear that 
abnormal  persistence  of  this  sensiti- 
zation uro&ss  contributes to sensorv 
disturb&es  experienced  by  many 
patients  with  -chronic  pain  syn- 
dromes  (3).  Low-grade  nociceptive 
input  aDDears  to-be  sufficient  to 
m&a&  kmptoms  of central  sensi- 
tization  ii; &stain  patients  with 
chronic pain syndromeS (4); in others, 
nociceptive input  seems  unnecessary 
(5),  implying  that  central  changes 
mediate sensorv disturbances (66). 
In many respects, the development 
of sensitivity  to normally  innocuous 
levels  of  light  and  noise  during 
headache  resembles  the  process  of 
“central  sensitization" demonstrated 
neurophysiologically  in  spinothala- 
mic tract neurons.  The persistence  of 
visual  and  auditorv  sensitivitv 
between  episodes  of  headache  ma; 
be  analog&s  to  the  persistence  of 
tenderness  for  hours  or  days  after 
injury.  In  this  issue  of  CepMal@z, 
VanagaiteVingen  and  colleagues 
report  on  sensitivity  to  light  and 
noise  in  patients  with  cluster  head- 
ache,  and  on  sensitivitv  to  noise  in 
mikaine.  Their  rem&  confirm  the 
cl&al  impressionAthat photophobia 
persists  between  attacks  during 
bouts  of  cluster  headache,  and  also 
demonstrate  that  patients  are  unus- 
ually  sensitive  to  noise  when  in  a 
bout.  Importantly,  Vanagaite-Vingen 
et  al.  found  that  sensitivity  to  light 
and  noise  returned  to  normal 
between  bouts  of  cluster  headache. 
In  contrast,  patients  with  migraine 
reported  that  discomfort  to  low 
levels  of noise  persisted  during  the 
headache-free  interval.  The  intensity 
of  phonophobia  between  attacks  of 
migraine  was  not  related  to  usual 
headache  frequency;  however,  the 
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association  between  phonophobia 
and  time  since  the  last  attack  was 
not  investigated,  leaving  open  the 
possibility that  this  symptom  might 
eventuaIly disappear in patients with 
infrequent attacks  (7). 
VanagaiteViis  findings empha- 
size that  sensory distu&nces  persist 
between  attacks  of  migraine  and 
cluster  headache.  Perhaps  these  dis- 
turbances  are  msiduaI  symptoms  of 
“central  sensitization”  (anal-  to 
tenderness after injury). Alternatively, 
they may be an indication of pen&tent 
low-grade  activation of peripheral or 
central  nociceptive  mechanisms  that 
contribute to  headache  (analogous to 
per&entsensorydMurban 
. 
certain  chrmlic  pain  syndronz).  z 
indeed  there  are  parallels  between 
sensitization  of  spinothalamic  tract 
neurons  and  the  mechamsms  that 
contribute to photophobia and phone 
phobia, then treatments which reverse 
central  sensitization  (e.g.,  8)  might 
decrease  susceptibility  to  headache; 
furthermore,  sensitivity to  light  and 
noise  may  turn  out  to  be  useful 
markers  of  the  effectiveness of  pre 
ventative therapy. 
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Deficient  interictal 
habituation 
Wei  Wang  and  Jean  Schoenen 
demonstrate  that  deficient  interictal 
habituation, expressed  by a potentia- 
tion  of  AEPs,  occurs  in  migraine 
patients.  This  is  a  very  important 
finding  since,  in  previously  pub- 
lished  contingent  negative  variation 
(CNV)  studies,  the  pronounced 
negativity in migraine patients could 
be  explained  by  higher  negative 
amplitudes,  due  to  greater  corticaI 
arousal,  and  also  by  reduced  habi- 
tuation  as  a  result  of  a  long-lasting 
orienting  reaction.  The basic  mecha- 
nism of increased  CNV negativity  is 
still  unknown.  The  present  publi- 
cation  supports  the  theory  of habit- 
uation-linked  changes  of  cortical 
potentials,  which  contradicts  simpli- 
fied aspects  of higher  cortical  activ- 
ity.  This  leads  to  an  interesting 
combination  of  psychological  and 
neurophysiological  factors  affecting 
habituation.  From  a  neurophysiolo- 
gical  point  of  view,  an  excessive 
lactate  accumulation  leads  to  meta- 
bolic changes.  Low serotonin activity 
correlates  with  deficient habituation 
parameters.  With  regard  to  psycho- 
logical  aspects,  habituation  is  the 
ability to  say  “no”  and  to learn  not 
to  react  to  all  stimuli.  Can  habitua- 
tion be trained  using  psychotherapy 
or  be  influenced  by  medication? 
What  are  the  reasons  for  metabolic 
disequilibrium in migraine  patients? 
When  did this d&habituation start- 
at  the  moment  of  the  first migraine 
attack  or  even  earlier?  What  are  the 
exact relations between behavior and 
neurotransmitter  change?  These 
questions will probably be answered 
in the next  few years. 
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Physical  therapy:  a role 
in  migraine? 
It  is  enigmatic  that,  in  some  circles, 
physical  therapy  is  prescriibed  for 
migraine.  Not  only  is  there  no  evi- 
dence  from  controlled  trials  that  it 
works,  there  is no  substantive  ratio 
nale  for  this  practice.  Perhaps  it  is 
based on the mistaken reason@  that, 
because  patients with  migraine exhi- 
bit tender neck muscles and impaired 
neck  movement,  physical  therapy 
should help their pain. This reasoning 
collapses  if  it  is  recognized  that 
muscle  tenderness  and  contraction 
are secondary to the pain of migraine. 
ThepaperbyMarcusetalinthis 
issue  should  bring  little  cheer  to 
proponents  of  physical  therapy. 
Their  study  1  shows  conclusively 
that  physical  therapy  is  ineffective 
for migraine. In the face of such data 
the  prescription  of  physical  therapy 
for migraine  should  cease,  wherever 
it remains  a fashion. 
Marcus  et  al.  concede  a  possible, 
but  selective,  role  for  physical 
therapy  in  the  management  of 
m&r-for  patients  wanting  non- 
pharmacological  treatment who  have 
failed relaxation and thermal biofeed- 
back.  The  data  in  support  of  this 
concession, however, are less compel- 
ling  than  those  of  study  1.  The 
authors  acknowledge  that  study  2 
was compnxnised  by a selection bias; 
only patients volunteering for further 
treatment entered the study.  Further- 
more,  the  group  sizes  were  smalk 
consequently the confidence intervals 
of  the  proportions  of  patients  who 
improved  are  large.  The  degree  of 
improvement  achieved  in  study  2 
was  less  than  that  in  study  1,  and 
the success rates cannot be compared. 
Consequently, despite  the  generosity 
of  the  authors  towards  physical 
therapy,  such  solam  as  might  be 
drawn from study 2 rests on a clinical 
effect that is mediocre  at best. 
N  &GDUK 
Sumatriptan  nasal  spray 
“Stratification”  of patients’  migraine 
by  analyzing  time  to peak  intensity, 
associated  disability  (e.g.,  nausea), 
and  overall  severity  often  suggests 
the  need  for  non-oral  treatment. 
Nasal  sprays  can  bypass  the  gastro- 
intesGnal tract. 
The article by Ashford et al. in this 
issue  is  a  post  hoc  meta-analysis  of 
2,395  patients  in  four  studies  on 
sumatriptan  nasal  spray.  It  is  an 
evaluation  of  the  consistency  of 
response  across  clinical  subtypes.  A 
concern  about  such  an  analysis 
(besides the obvious post hoc aspect) 
is the variability of placebo response. 
Fortunately  for  this  evaluation,  the 
relationship  between  active  treat- 
ment  and  placebo  did  not  vary 
much,  with  about  66%  of  patients 
treated  with sumatriptan  nasal spray 
and  33%  of  placebo-treated  patients 
obtaining headache  response  at  2 h. 
This  makes  subsequent  subgroup 
analysis more  credible. 
Sumatriptan  nasal  spray  showed 
no  significant  clinical  difference  for 
gender,  ethnicity,  adult  age,  weight, 
or migraine type. Use of concomitant 
prophylactic  medications  also  does 
not  affect  sumatriptan  nasal  spray 
effects,  unlike  rizatriptan,  which 
requires  a  lower  dose  for  patients 
on propranolol.  Not  surprisingly,  no 
patient  showed  any  “serotonin 
syndrome”-like  symptoms  when 
combining  sumatriptan  nasal  spray 
with  an SSRI. 
Dahlof  et  al.‘s  article  presents 
prospectively  gathered  patient  pre- 
ference data; 5%  preferred  the nasal 
spray  to  tablet,  46%  preferred  nasal 
spray to injection, and 68% described 
bitter  taste with  the  spray. 
Dahlof  raises  the  critical  issue  of 
where  the  spray  is  absorbed  and 
recommends  alternative  clinical 
instructions for minimizing bad taste 
and  maximizmg  nasal  mucosal 
absorption. 
The  two  articles  demonstrate  effi- 
cacy  and  speed,  suggesting  a highly 
useful  niche  for  the  spray  in  by- 
passing  the  gut.  It  may  be  useful 
to  provide  patients  with  a  “don’t 
mantra”  when  instructing  them  in 
sumatriptan  nasal  spray  use:  “don’t 
sniff, don’t  snort,  don’t  inhale, don’t 
swallow,  don’t  tilt  the  head  back, 
and  don’t  lie down!” 
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NK-mediated  links  for 
migraine 
Mosnaim  and  co-workers  have 
performed  an  interesting  study  of 
lymphocyte  trafficking  in  migraine, 
the. results  indicating  an  increase  of 
normal  T  cells  (CD3+)  and  overall 
of  natural  killer  (NK)  cell  subsets 
(CD16+,  CD56+)  (Cephalalgia 
1998;18:197-  201).  These  cellular 
phenotypes~were  more  in  evidence 
interictally  when  compared  to  dur- 
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ing  an  attack  and  healthy  subjects. 
What  does  this  mean?  Is  it relevant 
for headache?  How do these findings 
affect  the  most  widely  accepted 
hypotheses  for  migraine,  such  as 
“sterile  inflamma  tion”  or  the  “nitric 
oxide”  (NO) hypotheses? 
The biologic message. of this possi- 
bly  sentinel  study  might  stimulate 
speculation  about  the  importance  of 
the  basic  links between  the  NK  cell 
population  and  vascular/endothelial  .  udlammation  mediators (i.e., NO) and 
a  possible  role  in  the  molecular 
mechanisms  of  migraine  (1,  2).  The 
nitrinergic  network  in  migraine 
remains  to  be  determined  (3),  but 
the present results add to the soluticm. 
In  fact,  there  is  increasing  evidence 
that  NK  cell  activity  is  dire+ 
dependent upon  the concentration of 
L-arginine,  the  main  NO  precursor 
(4). The basal  NK  subset increase in 
migraine maybe  the ccmsequence of a 
similar incmase of NO synthase activ- 
ity  determined  by  nitrite  accumula- 
tion  (5). The possible role played  by 
thENKsubsetinmigraineemerges 
from  this  report,  although  further 
functional investigation is  needed  to 
identify  and  define  other  factors 
which could influence the NK activity 
and  the  fine  balance  operating 
between  neurotransmission  and 
immunocompetence  in migraine. 
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